Leukemia Panel tests in Dubai & UAE

Compare available Leukemia Panel tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,500.00–4,600.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Leukemia Panel test prices

Showing 1–9 of 9 matching tests.

Leukemia Panel diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1871 Acute Leukemia Panel Test This diagnostic test evaluates bone marrow or peripheral blood for the presence and classification of acute leukaemia cells using multiparametric flow cytometry.	Bone marrow aspirate or peripheral blood	1–2 days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leukaemia cell immunophenotype", "Minimal residual disease (MRD)"] Parameters [] Preparation ["Consult with your doctor regarding current medications, especially corticosteroids, immunosuppressants, or anticoagulants.", "Schedule a pre-test consultation to review current therapies."] Indications ["Suspicion of acute leukaemia", "Classification of acute leukaemia (AML, ALL, MPAL)", "Monitoring for minimal residual disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 58491-5 ICD-10: C91.00, C92.00, C95.00 Clinical summary This diagnostic test evaluates bone marrow or peripheral blood for the presence and classification of acute leukaemia cells using multiparametric flow cytometry.
TEST-1721 Chronic Leukemia Panel Test This test evaluates for chronic leukemia using multiparameter flow cytometry and next-generation sequencing to identify specific immunophenotypes and genetic mutations.	Peripheral blood or bone marrow aspirate	1–2 working days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leukemia-associated immunophenotypes", "BCR-ABL1 genetic aberration", "TP53 genetic aberration", "IGHV genetic aberration"] Parameters [{"name": "Multiparameter flow cytometry (≥10 markers)", "reference_range": null}, {"name": "BCR-ABL1 NGS", "reference_range": null}, {"name": "TP53 NGS", "reference_range": null}, {"name": "IGHV NGS", "reference_range": null}] Preparation ["Provide a doctor’s prescription", "Avoid anticoagulants as advised by the physician"] Indications ["Suspected chronic leukemia", "Confirmed chronic leukemia", "Diagnosis confirmation", "Leukemia subtype classification", "Guidance for targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 96669-7 ICD-10: C95.1 Clinical summary This test evaluates for chronic leukemia using multiparameter flow cytometry and next-generation sequencing to identify specific immunophenotypes and genetic mutations.
TEST-652 Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test This test identifies key genetic mutations in CLL patients to guide treatment decisions and predict disease prognosis.	Whole Blood (4 mL EDTA Lavender Top)	6 Days (Sample arrival Mon 11 AM → Report by Saturday)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TP53 mutation status", "ATM mutation status", "IGHV mutation status", "NOTCH1 mutation status", "SF3B1 mutation status", "BIRC3 mutation status", "MYD88 mutation status"] Parameters [{"name": "TP53", "reference_range": "Mutation detected / Not detected"}, {"name": "ATM", "reference_range": "Mutation detected / Not detected"}, {"name": "IGHV", "reference_range": "Mutated / Unmutated"}, {"name": "NOTCH1", "reference_range": "Mutation detected / Not detected"}, {"name": "SF3B1", "reference_range": "Mutation detected / Not detected"}, {"name": "BIRC3", "reference_range": "Mutation detected / Not detected"}, {"name": "MYD88", "reference_range": "Mutation detected / Not detected"}] Preparation ["No fasting required", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Diagnosis of Chronic Lymphocytic Leukemia (CLL)", "Risk stratification in CLL", "Guidance for targeted therapy selection in CLL"] Measurement technique Confirm with laboratory Codes LOINC: 69548-8 ICD-10: C91.1 Clinical summary This test identifies key genetic mutations in CLL patients to guide treatment decisions and predict disease prognosis.
TEST-2760 Chronic Myeloid Leukemia (CML) NGS Panel Test This test identifies genetic mutations associated with Chronic Myeloid Leukemia (CML), including BCR-ABL1 kinase domain mutations and other resistance variants.	Bone Marrow Aspirate or Peripheral Blood	15 business days (maximum)	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 kinase domain mutations", "Additional gene alterations driving CML progression (e.g., ABL1, ASXL1, RUNX1)"] Parameters [] Preparation ["Fasting for 8 hours prior to collection", "Complete the NGS Test Requisition Form", "Sample collection must occur at an accredited hospital facility"] Indications ["Diagnosis of CML", "Monitoring treatment response", "Detection of resistance mutations", "Guiding tyrosine kinase inhibitor selection"] Measurement technique Confirm with laboratory Codes LOINC: 92928-0 ICD-10: C92.10, C92.11, C92.12 Clinical summary This test identifies genetic mutations associated with Chronic Myeloid Leukemia (CML), including BCR-ABL1 kinase domain mutations and other resistance variants.
TEST-106 Comprehensive Leukemia Panel (SNVs, Small INDELs, CNVs) Test This test evaluates the genomic landscape of leukemia by detecting SNVs, INDELs, and CNVs in over 50 relevant genes using NGS.	Peripheral blood	14–21 business days	4,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Variants (SNVs)", "Small Insertions/Deletions (INDELs)", "Copy Number Variations (CNVs)", "Genomic mutations in >50 leukemia-associated genes"] Parameters [] Preparation ["No fasting required."] Indications ["Diagnosis of acute or chronic leukemia", "Risk stratification in leukemia", "Guidance for targeted therapy selection", "Monitoring minimal residual disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 91847-0 ICD-10: C95.9 Clinical summary This test evaluates the genomic landscape of leukemia by detecting SNVs, INDELs, and CNVs in over 50 relevant genes using NGS.
TEST-1607 Extended AML Panel (BCR/ABL, AML/ETO, CBFB, PML/RARA, FLT3, NPM1, CEBPA) Test This test identifies seven critical genetic mutations associated with Acute Myeloid Leukemia (AML) to guide prognosis and treatment decisions.	Bone marrow aspirate or peripheral blood	7–8 working days	3,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR/ABL fusion gene", "AML/ETO fusion gene", "CBFB fusion gene", "PML/RARA fusion gene", "FLT3 mutation", "NPM1 mutation", "CEBPA mutation"] Parameters [{"name": "BCR/ABL", "reference_range": "Negative"}, {"name": "AML/ETO", "reference_range": "Negative"}, {"name": "CBFB", "reference_range": "Negative"}, {"name": "PML/RARA", "reference_range": "Negative"}, {"name": "FLT3", "reference_range": "Negative"}, {"name": "NPM1", "reference_range": "Negative"}, {"name": "CEBPA", "reference_range": "Negative"}] Preparation ["No fasting required", "Inform doctor about all medications, especially blood thinners", "Valid prescription required"] Indications ["Diagnosis of acute myeloid leukemia", "Risk stratification in AML", "Selection of targeted therapy", "Minimal residual disease monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 60560-5 ICD-10: C92.00 Clinical summary This test identifies seven critical genetic mutations associated with Acute Myeloid Leukemia (AML) to guide prognosis and treatment decisions.
TEST-1175 FISH Eosinophilic Leukemia Panel (Fluorescence In-Situ Hybridization) Test This test identifies specific chromosomal rearrangements (PDGFRA, PDGFRB, FGFR1, PCM1-JAK2) in blood or bone marrow cells using FISH.	Peripheral whole blood (sodium heparin) or bone marrow aspirate	4 Working Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFRA rearrangements", "PDGFRB rearrangements", "FGFR1 rearrangements", "PCM1-JAK2 rearrangements"] Parameters [] Preparation [] Indications ["Suspected eosinophilic leukemia", "Differentiation of reactive eosinophilia from clonal disorders", "Guidance for targeted tyrosine kinase inhibitor therapy"] Measurement technique Confirm with laboratory Codes LOINC: 60540-3 ICD-10: C94.8 Clinical summary This test identifies specific chromosomal rearrangements (PDGFRA, PDGFRB, FGFR1, PCM1-JAK2) in blood or bone marrow cells using FISH.
TEST-2786 ONCOMINE Acute Myeloid Leukaemia (AML) Panel Test This test identifies genetic mutations in over 25 genes relevant to Acute Myeloid Leukaemia (AML) using Next-Generation Sequencing.	Blood (Lavender-top EDTA tube) or Bone Marrow Aspirate	15 working days (monthly batch processing)	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in NPM1 gene", "Mutations in FLT3 gene", "Mutations in IDH1 gene", "Mutations in IDH2 gene", "Mutations in CEBPA gene", "Other AML-associated gene mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab if patient received bone marrow transplant within 28 days", "Ensure fully completed NGS Requisition Form (Form 40) is provided"] Indications ["Diagnosis of Acute Myeloid Leukaemia", "Risk stratification in AML", "Guidance for targeted therapy selection", "Monitoring for minimal residual disease (if applicable)"] Measurement technique Confirm with laboratory Codes LOINC: 88229-0 ICD-10: C92.00 Clinical summary This test identifies genetic mutations in over 25 genes relevant to Acute Myeloid Leukaemia (AML) using Next-Generation Sequencing.
TEST-2795 Oncomine Juvenile Myelomonocytic Leukemia (JMML) Panel Test This diagnostic test evaluates the genetic mutations in 42 key genes associated with juvenile myelomonocytic leukemia (JMML) using next-generation sequencing.	Bone marrow aspirate or peripheral whole blood (EDTA)	Batch processing: sample by 1st/16th, report 15th/30th same month	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Insertions/deletions (Indels)", "Copy number alterations (CNAs)", "Mutations in 42 specific genes (e.g., PTPN11, NRAS, KRAS, NF1, CBL)"] Parameters [] Preparation ["No specific patient preparation required."] Indications ["Suspicion of juvenile myelomonocytic leukemia", "Risk stratification in JMML", "Guiding targeted therapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 96972-0 ICD-10: C93.3 Clinical summary This diagnostic test evaluates the genetic mutations in 42 key genes associated with juvenile myelomonocytic leukemia (JMML) using next-generation sequencing.

Category overview

Leukemia Panel: overview

Navigating a complex blood disorder diagnosis demands comprehensive, high-resolution insights to unlock the most effective, personalized treatment strategy. Within our elite Hematology and Oncology department, the Leukemia Panel combines advanced flow cytometry and molecular evaluations to thoroughly assess abnormal white blood cells. By leveraging state-of-the-art diagnostic technology, this expansive molecular screening delivers the definitive data needed to accurately sub-classify the disease, safely guiding your healthcare provider in tailoring highly targeted, life-saving oncology protocols. Recognized for clinical excellence among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, uncompromising diagnostic accuracy, and remarkably fast turnaround times. Take control of your specialized cancer care—book your leukemia panel testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical specialists today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.